| Literature DB >> 30940318 |
I R Lake1, F J Colón-González1, J Takkinen2, M Rossi2, B Sudre2, J Gomes Dias2, L Tavoschi2, A Joshi2, J C Semenza2, G Nichols2,3,1,4,5.
Abstract
BackgroundCampylobacteriosis is the most commonly reported food-borne infection in the European Union, with an annual number of cases estimated at around 9 million. In many countries, campylobacteriosis has a striking seasonal peak during early/mid-summer. In the early 2000s, several publications reported on campylobacteriosis seasonality across Europe and associations with temperature and precipitation. Subsequently, many European countries have introduced new measures against this food-borne disease.AimTo examine how the seasonality of campylobacteriosis varied across Europe from 2008-16, to explore associations with temperature and precipitation, and to compare these results with previous studies. We also sought to assess the utility of the European Surveillance System TESSy for cross-European seasonal analysis of campylobacteriosis.MethodsWard's Minimum Variance Clustering was used to group countries with similar seasonal patterns of campylobacteriosis. A two-stage multivariate meta-analysis methodology was used to explore associations with temperature and precipitation.ResultsNordic countries had a pronounced seasonal campylobacteriosis peak in mid- to late summer (weeks 29-32), while most other European countries had a less pronounced peak earlier in the year. The United Kingdom, Ireland, Hungary and Slovakia had a slightly earlier peak (week 24). Campylobacteriosis cases were positively associated with temperature and, to a lesser degree, precipitation.ConclusionAcross Europe, the strength and timing of campylobacteriosis peaks have remained similar to those observed previously. In addition, TESSy is a useful resource for cross-European seasonal analysis of infectious diseases such as campylobacteriosis, but its utility depends upon each country's reporting infrastructure.Entities:
Keywords: Campylobacter; campylobacteriosis; climate change; food-borne infections; gastrointestinal disease; laboratory surveillance; surveillance
Year: 2019 PMID: 30940318 PMCID: PMC6446507 DOI: 10.2807/1560-7917.ES.2019.24.13.180028
Source DB: PubMed Journal: Euro Surveill ISSN: 1025-496X
Total, mean annual and mean weekly confirmed reported campylobacteriosis cases by country, EU/EEAa, 2008–2016 (n = 1,844,004)
| Countries | Campylobacteriosis cases | Mean annual count | Mean annual incidence | Mean weekly count | Mean weekly incidence | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | Total | |||||
| Austria | 3,857 | 4,150 | 3,968 | 5,073 | 4,695 | 5,159 | 5,922 | 5,645 | 6,460 | 44,929 | 4,992 | 59.0 | 95.8 | 1.1 |
| Belgium | 5,079 | 5,684 | 6,038 | 7,669 | 6,771 | 8,117 | 7,963 | NA | NA | 47,321 | 5,258 | 47.9 | 129.6 | 1.2 |
| Cyprus | 23 | 37 | 55 | 62 | 68 | 57 | 39 | 29 | 21 | 391 | 43 | 3.9 | 1.7 | 0.1 |
| Czech Republic | 19,847 | 20,035 | 20,869 | 18,479 | 18,102 | 17,971 | 20,501 | 20,670 | 23,811 | 180,285 | 20,032 | 191.1 | 384.4 | 3.7 |
| Denmark | 2,898 | 2,903 | 3,378 | 3,392 | 3,199 | 3,193 | 3,218 | 3,670 | 3,824 | 29,675 | 3,297 | 59.0 | 63.3 | 1.1 |
| Estonia | 132 | 159 | 178 | 195 | 258 | 360 | 268 | 300 | 281 | 2,131 | 237 | 17.9 | 4.9 | 0.4 |
| Finland | 1,963 | 1,582 | 1,536 | 1,866 | 2,289 | 2,043 | 2,415 | 2,702 | 2,788 | 19,184 | 2,132 | 39.4 | 40.9 | 0.8 |
| France | 3,300 | 3,832 | 4,211 | 5,383 | 5,086 | 5,242 | 5,934 | 6,065 | 6,676 | 45,729 | 5,081 | 7.7 | 97.5 | 0.1 |
| Germany | 60,522 | 58,764 | 61,104 | 66,214 | 58,278 | 58,165 | 64,798 | 63,792 | 68,086 | 559,723 | 62,191 | 76.4 | 1,193.4 | 1.5 |
| Hungary | 5,489 | 6,582 | 7,157 | 6,102 | 6,413 | 7,238 | 8,406 | 8,352 | 8,513 | 64,252 | 7,139 | 71.9 | 137.0 | 1.4 |
| Iceland | 93 | 46 | 33 | 78 | 30 | 61 | 83 | 61 | 70 | 555 | 62 | 19.1 | 2.3 | 0.7 |
| Ireland | 1,728 | 1,770 | 1,614 | 2,426 | 2,394 | 2,284 | 2,577 | 2,438 | 2,503 | 19,734 | 2,193 | 47.7 | 42.1 | 0.9 |
| Italy | 260 | 505 | 397 | 441 | 727 | 1,138 | 1,186 | 962 | 1,007 | 6,623 | 736 | 1.2 | 14.9 | 0.0 |
| Latvia | NA | NA | NA | 7 | 8 | 9 | 37 | 74 | 89 | 224 | 37 | 1.3 | 1.9 | 0.1 |
| Lithuania | 759 | 817 | 1,089 | 1,124 | 926 | 1,126 | 1,170 | 1,178 | 1,217 | 9,406 | 1,045 | 34.6 | 20.1 | 0.7 |
| Luxembourg | 464 | 521 | 600 | 704 | 587 | 676 | 866 | 254 | 518 | 5,190 | 577 | 109.8 | 11.1 | 2.1 |
| Malta | 77 | 130 | 203 | 216 | 223 | 243 | 288 | 248 | 210 | 1,838 | 204 | 48.0 | 4.6 | 1.1 |
| Netherlands | 3,179 | 3,562 | 4,071 | 4140 | 4,077 | 3,505 | 3,976 | 3,562 | 3,071 | 33,143 | 3,682 | 22.0 | 70.8 | 0.4 |
| Norway | 1,329 | 1,498 | 1,305 | 1,524 | 1,523 | 1,539 | 1,832 | 1,131 | 1,201 | 12,882 | 1,431 | 28.8 | 27.5 | 0.6 |
| Poland | 267 | 357 | 365 | 352 | 429 | 551 | 643 | 650 | 769 | 4,383 | 487 | 1.3 | 20.3 | 0.1 |
| Portugal | NA | NA | NA | NA | NA | NA | 1 | 266 | 356 | 623 | 208 | 0.7 | 6.0 | 0.1 |
| Romania | NA | NA | NA | 149 | 92 | 217 | 256 | 311 | 517 | 1,542 | 257 | 0.9 | 5.8 | 0.0 |
| Slovakia | 3,048 | 3,784 | 4,457 | 4,541 | 5,686 | 5,819 | 6,705 | 6,903 | 7,581 | 48,524 | 5,391 | 99.7 | 103.5 | 1.9 |
| Slovenia | 898 | 948 | 1,017 | 991 | 998 | 1,003 | 1,179 | 1,294 | 1,622 | 9,950 | 1,106 | 53.9 | 21.2 | 1.0 |
| Spain | 5,414 | 5,279 | 6,304 | 5,473 | 5,777 | 7,436 | 11,818 | 13,541 | 15,848 | 76,890 | 8,573 | 18.5 | 164.5 | 0.4 |
| Sweden | 2,279 | 7,167 | 3,531 | 3,659 | 3,504 | 3,708 | 4,139 | 5,051 | 7,156 | 40,194 | 4,466 | 46.9 | 85.7 | 0.9 |
| UK | 54,570 | 64,089 | 69,613 | 71,530 | 72,463 | 65,544 | 66,053 | 57,687 | 57,134 | 578,683 | 64,298 | 101.4 | 1,233.9 | 1.9 |
| Total | 177,475 | 194,201 | 203,093 | 211,790 | 204,603 | 202,404 | 222,273 | 206,836 | 221,329 | 1,844,004 | 204919 | 41.9 | 3927.3 | 0.8 |
EU/EEA: European Union/European Economic Area; UK: United Kingdom. NA: not applicable.
a Twenty-seven of 31 countries reporting.
Figure 1Weekly confirmed reported campylobacteriosis cases by country, EU/EEAa, 2008–2016 (n = 1,844,004)
Week of maximum number of reported campylobacteriosis cases and proportion of cases occurring within a specified series of weeks during the estimated peak, EU/EEA countriesa, 2008–2016 (n = 1,784,996)
| Country | Nylen methodology [ | Results from Nylen study [ | Kovats methodology [ | Results from Kovats study [ | |||||
|---|---|---|---|---|---|---|---|---|---|
| Mean peak week | Proportion of cases within a number of weeks from peak | Mean peak weekb | Proportion of cases + / − 4 weeks from peak | Mean peak week | Mean peak weekc | ||||
| + / − 1 week | + / − 2 week | + / − 3 week | + / − 4 week | ||||||
| Austria | 27 | 0.09 | 0.14 | 0.19 | 0.25 | NA | 0.26 | 27 | NA |
| Czech Republic | 31 | 0.09 | 0.14 | 0.19 | 0.46 | NA | NA | 32 | 33 |
| Germany | 28 | 0.09 | 0.15 | 0.20 | 0.26 | NA | NA | 28 | NA |
|
|
|
|
|
|
| NA | NA |
| NA |
| Denmark | 32 | 0.13 | 0.21 | 0.28 | 0.34 | 32 | 0.30 | 32 | 32 |
| Sweden | 31 | 0.11 | 0.18 | 0.24 | 0.29 | 33 | 0.28 | 31 | NA |
|
|
|
|
| 0.27 |
| NA | NA |
| NA |
| Finland | 29 | 0.16 | 0.25 | 0.33 | 0.40 | 31 | 0.34 | 29 | NA |
| Norway | 30 | 0.16 | 0.26 | 0.35 | 0.42 | NA | NA | 30 | NA |
|
|
|
|
|
|
| NA | NA |
| NA |
| France | 34 | 0.09 | 0.15 | 0.20 | 0.25 | NA | NA | 29 | NA |
| Italy | 32 | 0.10 | 0.15 | 0.20 | 0.25 | NA | NA | 31 | NA |
| Lithuania | 31 | 0.09 | 0.15 | 0.21 | 0.26 | NA | NA | 31 | NA |
| Luxembourg | 25 | 0.09 | 0.14 | 0.19 | 0.24 | NA | NA | 24 | NA |
| Netherlands | 24 | 0.09 | 0.14 | 0.19 | 0.24 | NA | NA | 23 | 34 |
| Slovenia | 30 | 0.09 | 0.14 | 0.20 | 0.26 | NA | NA | 33 | NA |
|
|
|
|
|
|
| NA | NA |
| NA |
| Hungary | 23 | 0.08 | 0.13 | 0.17 | 0.22 | NA | NA | 24 | NA |
| Ireland | 21 | 0.09 | 0.14 | 0.18 | 0.23 | NA | NA | 20 | 31 |
| Slovakia | 24 | 0.10 | 0.16 | 0.22 | 0.27 | NA | NA | 23 | NA |
| UKe | 25 | 0.08 | 0.14 | 0.19 | 0.24 | 25 | 0.24 | 24 | 23 |
|
|
|
|
|
|
| NA | NA |
| NA |
| Spain | 22 | 0.07 | 0.12 | 0.16 | 0.21 | NA | NA | 23 | 26 |
|
| 22 | 0.07 | 0.12 | 0.16 | 0.21 | NA | NA | 23 | 26 |
EU/EEA: European Union/European Economic Area; NA: not applicable; UK: United Kingdom.
a Eighteen countries.
b Comparative data from [5]. Date is laboratory report date.
c Comparative data from [11]. Date is calculated as two weeks post estimated date of onset.
d Based upon all data within the cluster; hence, not the mean of the countries within each cluster.
eUK data from [5] are for Wales and Scotland only and do not include England or Northern Ireland; UK data from [11] are for England and Wales and do not include Scotland and Northern Ireland.
Figure 2Dendrogram showing clusters of countries with seasonal trends in reported campylobacteriosis cases’ weekly incidence, 18 EU/EEA countries, 2008–2016
Figure 3Seasonal trends in reported campylobacteriosis weekly incidence for the six clusters, 18 EU/EEA countries, 2008–2016 (n = 1,784,996)
Figure 4Influence of (A) temperature and (B) precipitation on the relative risk of Campylobacter¸ 18 EU/EEA countries, 2008–2016